AtriCure, Inc. - Common Stock (ATRC)
30.30
-4.35 (-12.55%)
NASDAQ · Last Trade: Apr 30th, 1:24 PM EDT
Via Benzinga · April 30, 2025

Via Benzinga · February 10, 2025

Via Benzinga · January 22, 2025

Via Benzinga · December 9, 2024

Via Benzinga · January 22, 2025

Via Benzinga · October 30, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 29, 2024

Via Benzinga · May 2, 2024

ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 30, 2024

Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.
Via InvestorPlace · June 28, 2024

ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · February 16, 2024

Via Benzinga · February 16, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via Benzinga · February 15, 2024